Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/11/2010US20100063149 Food composition for binding acetaldehyde in mouth and in digestive track, and method for the preparation of the composition
03/11/2010US20100063148 Antiepileptic agent in combination with tapentadol; use treating pain including cancer pain and neuropathic pain; synergistic
03/11/2010US20100063147 Anaplerotic Therapy of Huntington Disease and Other Polyglutamine Diseases
03/11/2010US20100063146 Method for treating disorders related to complement activation
03/11/2010US20100063145 Acid containing oxaliplatin formulations
03/11/2010US20100063144 Compounds and uses thereof
03/11/2010US20100063142 o/w/o EMULSION CONTAINING LIGNAN COMPOUNDS AND COMPOSITION CONTAINING THE SAME
03/11/2010US20100063141 Deuterated benzylbenzene derivatives and methods of use
03/11/2010US20100063140 Water-soluble compositions of bioactive lipophilic compounds
03/11/2010US20100063138 Novel substituted sulfamide derivatives
03/11/2010US20100063137 Cytotoxin Compound And Method of Isolation
03/11/2010US20100063135 Polyethylene glycol lipid conjugates and uses thereof
03/11/2010US20100063134 comprising the steps of surgically implanting a catheter ; without impairment of cell endoplasmic reticulum, spontaneous motor activity, or locomotor activity; Alzheimer's, Parkinson's, Huntington's diseases, Spinocerebellar Ataxia Type 1, Type 2, Type 3, and/or dentatorubral-pallidoluysian atrophy
03/11/2010US20100063133 Antisense antiviral compound and method for treating arenavirus infection
03/11/2010US20100063132 Small interfering rna and pharmaceutical composition for treatment of hepatitis b comprising the same
03/11/2010US20100063131 Prompt nucleic acid delivery carrier composition
03/11/2010US20100063130 Method for promoting immune response comprising inhibiting cd22 function in b cells
03/11/2010US20100063129 4-Diallylaminomethylene-6-hydroxy-1- alpha -methoxymethyl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta ,12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta[ alpha ] phenanthren-11-ol or its acetate in a carrier; PI-3 kinase inhibitor; treating color cancer
03/11/2010US20100063128 Indole compounds, a process for their preparation and pharmaceutical compositions containing them.
03/11/2010US20100063127 Antioxidant Properties of Tryptophan from Human Milk
03/11/2010US20100063126 Carbazole-Derived Pharmaceutical Compositions
03/11/2010US20100063125 Melatonin derivatives and their use as antioxidants
03/11/2010US20100063124 New pyrazole derivatives and diabetic medicine containing them
03/11/2010US20100063123 Extended release formulation and method of treating adrenergic dysregulation
03/11/2010US20100063122 NOVEL 2-(2-HYDROXYPHENYL)BENZIMlDAZOLES USEFUL FOR TREATING OBESITY AND DIABETES
03/11/2010US20100063121 Macrocyclic Heterocyclic Aspartyl Protease Inhibitors
03/11/2010US20100063120 Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such
03/11/2010US20100063119 Substituted carbinol compound
03/11/2010US20100063118 Hydantoins Having RNase Modulatory Activity
03/11/2010US20100063117 Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient
03/11/2010US20100063116 Use of pramipexole or a salt thereof for the treatment of parkinson's disease
03/11/2010US20100063115 5-(1,3,4-oxadiazol-2-yl)-1h-indazole and 5-(1,3,4-thiadiazol-2-yl)-1h-indazole derivatives as sgk inhibitors for the treatment of diabetes
03/11/2010US20100063114 Inhibitors of protein prenyltransferases
03/11/2010US20100063113 Novel pharmaceutical salts and polymorphs of a factor xa inhibitor
03/11/2010US20100063112 Polymorph iii of 4-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
03/11/2010US20100063111 Formulation and use and manufacture thereof
03/11/2010US20100063110 Orally administrable films
03/11/2010US20100063109 Thiadiazolidinone derivatives
03/11/2010US20100063108 Pyridin-4-yl derivatives as immunomodulating agents
03/11/2010US20100063107 Hydroxy methyl phenyl pyrazolyl urea compounds usefull in the treatment of cancer
03/11/2010US20100063106 Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
03/11/2010US20100063105 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides
03/11/2010US20100063104 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
03/11/2010US20100063103 (3-{[2-(Benzenesulfonyl)pyridin-3-yl]methyl}-5-fluoro-2-methylindol-1-yl)-acetic acid, used in the treatment of allergic or inflammatory diseases mediated by prostaglandin D2 (PGD2) or other agonists acting at the oattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) receptor
03/11/2010US20100063102 Treatment of faecal incontinence
03/11/2010US20100063101 New benzimidazole derivatives
03/11/2010US20100063100 Modulators of aldehyde dehydrogenase activity and methods of use thereof
03/11/2010US20100063099 Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens
03/11/2010US20100063098 Pyridone derivatives as p38a mapk inhibitors
03/11/2010US20100063097 Azabicyclo [3.1.0] Hexane Derivatives as Modulators of Dopamine D3 Receptors
03/11/2010US20100063096 Biphenyl compounds useful as muscarinic receptor antagonists
03/11/2010US20100063095 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/11/2010US20100063094 Methods for treatment of colorectal cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/11/2010US20100063093 Methods for the administration of iloperidone
03/11/2010US20100063092 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
03/11/2010US20100063091 Renin inhibitors
03/11/2010US20100063089 Succinate salt of 2-((4-(1-methyl-4-pyridin-4-yl)-1h-pyrazol-3-yl)phenoxy)methyl)quinoline
03/11/2010US20100063088 Raf Kinase Inhibitors
03/11/2010US20100063087 5-Amino-4-Hydroxy-7-(Imidazo [1,2-A] Pyridin-6-Ylmethyl)-8-Methyl-Nonamide Derivatives and Related Compounds as Renin Inhibitors for the Treatment of Hypertension
03/11/2010US20100063086 Pharmaceutical compounds
03/11/2010US20100063085 Method of treating learning impairment in down's syndrome subjects
03/11/2010US20100063084 Multi-phase release methscopolamine compositions
03/11/2010US20100063083 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer
03/11/2010US20100063082 Camptothecin derivatives with antitumor activity
03/11/2010US20100063081 CPCR Agonists
03/11/2010US20100063080 CXCR2 inhibitors
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063078 Spirocompounds useful as modulators for dopamine d3 receptors
03/11/2010US20100063077 Pyrimidine derivatives for the treatment of amyloid-related diseases
03/11/2010US20100063076 Endothelin receptor antagonists
03/11/2010US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
03/11/2010US20100063074 Cancer Treatment Method
03/11/2010US20100063073 Methods and Compositions Utilizing Quinazolinones
03/11/2010US20100063072 Solid forms of pemetrexed
03/11/2010US20100063071 Therapeutic compositions and related methods of use
03/11/2010US20100063070 Combination for use in the treatment of inflammatory disorders
03/11/2010US20100063069 Gyrase inhibitors and uses thereof
03/11/2010US20100063068 Compounds for the Treatment of Hepatitis C
03/11/2010US20100063067 Cyclic derivatives as modulators of chemokine receptor activity
03/11/2010US20100063066 Raf inhibitor compounds and methods of use thereof
03/11/2010US20100063065 Thiophene derivatives as ppar agonists i
03/11/2010US20100063064 3-(4-Fluoro-2-methyl-phenyl)-6-[5-methoxymethyl-4-(6-methoxy-pyridin-3-yl)-4H-[1,2,4]triazol-3-yl]-pyridazine; treatment of male sexual dysfunction, female sexual dysfunction, hypoactive sexual desire disorder, sexual arousal disorder, orgasmic disorder, sexual pain disorder, or premature ejaculation
03/11/2010US20100063063 Substituted Heteroaryls
03/11/2010US20100063062 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
03/11/2010US20100063061 Antibacterial quinoline derivatives
03/11/2010US20100063060 Therapeutic agent for glaucoma comprising Rho Kinhase inhibitor and prostaglandin
03/11/2010US20100063059 Novel pyridazine compound and use thereof
03/11/2010US20100063058 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
03/11/2010US20100063057 Compositions and methods for delivery of anti-cancer agents
03/11/2010US20100063056 Bipyridine carboxamide orexin receptor antagonists
03/11/2010US20100063055 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
03/11/2010US20100063054 cMET INHIBITORS
03/11/2010US20100063053 Heterocyclic inhibitors of mek and methods of use thereof
03/11/2010US20100063052 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
03/11/2010US20100063051 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/11/2010US20100063050 Novel heteropyrrole analogs acting on cannabinoid receptors
03/11/2010US20100063049 2-carbocycloamino-4-imidazolylpyrimidines as agents for the inhbition of cell proliferation
03/11/2010US20100063048 Remedy for angiospasm accompanying subarachnoid hemorrhage containing thrombin receptor antagonist as the active ingredient
03/11/2010US20100063047 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
03/11/2010US20100063046 Tetracyclic imidazole analogs
1 ... 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 ... 7860